Ministry of Education Key Laboratory for the Green Preparation and Application of Functional Materials, Hubei Key Laboratory of Polymer Materials, School of Materials Science and Engineering, Hubei University, Wuhan, 430062, Hubei, China.
College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou, 535011, China.
J Nanobiotechnology. 2022 Oct 23;20(1):457. doi: 10.1186/s12951-022-01661-w.
Due to the urgent demand for more anti-cancer methods, the new applications of metal ions in cancer have attracted increasing attention. Especially the three kinds of the new mode of cell death, including ferroptosis, calcicoptosis, and cuproptosis, are of great concern. Meanwhile, many metal ions have been found to induce cell death through different approaches, such as interfering with osmotic pressure, triggering biocatalysis, activating immune pathways, and generating the prooxidant effect. Therefore, varieties of new strategies based on the above approaches have been studied and applied for anti-cancer applications. Moreover, many contrast agents based on metal ions have gradually become the core components of the bioimaging technologies, such as MRI, CT, and fluorescence imaging, which exhibit guiding significance for cancer diagnosis. Besides, the new nano-theranostic platforms based on metal ions have experimentally shown efficient response to endogenous and exogenous stimuli, which realizes simultaneous cancer therapy and diagnosis through a more controlled nano-system. However, most metal-based agents have still been in the early stages, and controlled clinical trials are necessary to confirm or not the current expectations. This article will focus on these new explorations based on metal ions, hoping to provide some theoretical support for more anti-cancer ideas.
由于对更多抗癌方法的迫切需求,金属离子在癌症中的新应用引起了越来越多的关注。特别是三种新的细胞死亡模式,包括铁死亡、钙死亡和铜死亡,备受关注。同时,许多金属离子已被发现通过不同的途径诱导细胞死亡,例如干扰渗透压、引发生物催化、激活免疫途径和产生促氧化剂效应。因此,基于上述方法的各种新策略已被研究和应用于抗癌应用。此外,许多基于金属离子的对比剂已逐渐成为磁共振成像(MRI)、计算机断层扫描(CT)和荧光成像等生物成像技术的核心组成部分,为癌症诊断提供了指导意义。此外,基于金属离子的新型纳米治疗平台已通过实验证明对内源性和外源性刺激具有高效响应,通过更可控的纳米系统实现了癌症治疗和诊断的同步。然而,大多数基于金属的药物仍处于早期阶段,需要进行对照临床试验来确认或否定目前的预期。本文将重点介绍基于金属离子的这些新探索,希望为更多抗癌思路提供一些理论支持。